Age-related maculopathy in a multiracial United States population: The National Health and Nutrition Examination Survey III

Ophthalmology

Volumn 106, Issue 6, 1999, Pages 1056-1065

  Klein, Ronald ^a,b   Klein, Barbara E K ^a   Jensen, Susan C ^a   Mares Perlman, Julie A ^a   Cruickshanks, Karen J ^a   Palta, Mari ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; DRUSEN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULOPATHY; RISK FACTOR; UNITED STATES;

EID: 0033497453     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(99)90255-5     Document Type: Article

References (33)

1. Vision Problems in the U.S.: A Statistical Analysis. Prepared by Operational Research Department National Society to Prevent Blindness. New York: The Society, 1980; 1-46. Available from: National Society to Prevent Blindness. 500 East Remington Rd., Schaumburg, IL 60173.
2. Klein R, Wang Q, Klein BEK, et al. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 1995;36:182-91.
3. Klein R, Klein BEK, Lee KE. Changes in visual acuity in a population. The Beaver Dam Eye Study. Ophthalmology 1996;103:1169-78.
4. Klein BEK, Klein R. Cataracts and macular degeneration in older Americans. Arch Ophthalmol 1982;100:571-3.
5. Klein R, Rowland ML, Harris MI. Racial/ethnic differences in age-related maculopathy. Third National Health and Nutrition Examination Survey. Ophthalmology 1995;102:371-81.
6. Schachat AP, Hyman L, Leske MC, et al. Features of age-related macular degeneration in a black population. The Barbados Eye Study Group. Arch Ophthalmol 1995;113:728-35.
7. Cruickshanks KJ, Hamman RF, Klein R, et al. The prevalence of age-related maculopathy by geographic region and ethnicity. The Colorado-Wisconsin Study of Age-Related Maculopathy. Arch Ophthalmol 1997;115:242-50.
8. Schatz H. The senile maculopathies and the retinal pigment epithelium. Int Ophthalmol Clin 1975;15:169-80.
9. Chumbley LC. Impressions of eye diseases among Rhodesian blacks in Mashonaland. S Afr Med J 1977;52:316-8.
10. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol 1988;32:375-413.
11. Jampol LM, Tielsch J. Race, macular degeneration, and the Macular Photocoagulation Study [editorial]. Arch Ophthalmol 1992;110:1699-700.
12. Gass JDM. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol 1973;90:206-17.
13. National Center for Health Statistics. Plan and Operation of the NHANES III. United States, 1988-1994. Vital Health Stat 1994;1(32).
14. Ezzati TM, Massey JT, Waksberg J, et al. Sample design: Third National Health and Nutrition Examination Survey. Vital Health Stat 2 1992;113:1-35.
15. National Center for Health Statistics. National Health and Nutrition Examination Survey III. United States, 1988-1994. Accounting for item nonresponse bias. Hyattsville, MD.: U.S. Department of Health and Human Services, 1994;1-66.
16. National Center for Health Statistics. National Health and Nutrition Examination Survey III data collection forms. Hyattsville, MD.: U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control, National Center for Health Statistics, 1990.
17. Klein R, Meuer SM, Moss SE, Klein BEK. Detection of drusen and early signs of age-related maculopathy using a nonmydriatic camera and a standard fundus camera. Ophthalmology 1992;99:1686-92.
18. Klein R, Davis MD, Magli YL, et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991;98: 1128-34.
19. Fleiss JL. Statistical Methods for Rates and Proportions, 2nd ed. New York: Wiley, 1981;219 (Wiley series in Probability and Mathematical Statistics).
20. Berglund P. Using SAS For Variance Estimation With Complex Sample Surveys. Midwest SAS Users Group Conference Proceedings, 1997;199-207.
21. Shah BV, Barnwell BG, Bieler GS. SUDAAN User's Manual, Release 7.0. Research Triangle Park, NC, 1996.
22. Mohadjer L, Montaquila J, Waksberg J, et al. NHANES III Weighting And Estimation Methodology Executive Summary. Rockville, MD: Westat, Inc., 1996.
23. Bischoff PM, Flower RW. High blood pressure in choroidal arteries as a possible pathogenetic mechanism in senile macular degeneration. Am J Ophthalmol 1983;96:398-9.
24. Moore DJ, Hussain AA, Marshall J. Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci 1995;36:1290-7.
25. Klein R, Klein BEK, Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1993;100:406-14.
26. Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 1998;116:583-7.
27. Klein R, Klein BEK, Jensen SC. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1997;104:1804-12.
28. Vingerling JR, Dielemans I, Bots ML, et al. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 1995;142:404-9.
29. Klein R, Klein BEK, Linton KL, DeMets DL. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol 1993;137:190-200.
30. Vingerling JR, Klaver CC, Hofman A, de Jong PT. Epidemiology of age-related maculopathy. Epidemiol Rev 1995;17: 347-60.
31. Smith W, Mitchell P, Leeder SR. Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol 1996;114:1518-23.
32. Klein BEK, Klein R, Jensen SC, Ritter LL. Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study. Trans Am Ophthalmol Soc 1994;92:289-97.
33. Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch Ophthalmol 1992;110:1701-8.